Carboxypeptidase A2
Carboxypeptidase A2 (CPA2) is an enzyme that in humans is encoded by the CPA2 gene. This enzyme is part of the metallocarboxypeptidase family, which is involved in the catabolism and modification of proteins. Carboxypeptidases remove amino acids from the carboxyl end of proteins or peptides. CPA2 is specifically involved in the digestion of food proteins in the digestive system, making it crucial for the proper absorption of dietary proteins.
Function[edit | edit source]
Carboxypeptidase A2 is a pancreatic enzyme that plays a significant role in the digestive system. It works by cleaving the C-terminal amino acid from peptide chains, a process essential for the complete digestion of food proteins into absorbable units. This enzyme is particularly important in the breakdown of complex dietary proteins into simpler amino acids, which can then be absorbed by the intestines and utilized by the body for various physiological functions, including tissue repair and growth.
Structure[edit | edit source]
The structure of CPA2 is characterized by a zinc ion that is essential for its enzymatic activity. This zinc ion is located at the active site of the enzyme and plays a critical role in the catalysis of peptide bond hydrolysis. The enzyme's structure is designed to bind specifically to the C-terminal end of peptide chains, allowing for precise and efficient cleavage of amino acids.
Genetics[edit | edit source]
The CPA2 gene is located on chromosome 7 in humans. Mutations in this gene are rare but can affect the enzyme's function, potentially leading to digestive problems due to the inefficient breakdown of dietary proteins. The genetic regulation of CPA2 expression is complex and involves various factors, including hormonal signals that correspond to the digestive process.
Clinical Significance[edit | edit source]
While mutations in the CPA2 gene are uncommon, the role of CPA2 in the digestive system makes it a potential target for therapeutic intervention in conditions related to protein malabsorption or digestive inefficiencies. Inhibitors of CPA2 could also be of interest in the context of certain diseases where the modulation of protein breakdown could have therapeutic benefits.
See Also[edit | edit source]
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD